RT Journal Article
SR Electronic
T1 Re-opening schools in a context of low COVID-19 contagion: Consequences for teachers, students and their parents
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.25.21254219
DO 10.1101/2021.03.25.21254219
A1 Anna Godøy
A1 Maja Weemes Grøtting
A1 Rannveig Kaldager Hart
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254219.abstract
AB To balance children’s right to schooling with contagion management, knowing how school re-openings affect the spread of SARS-CoV-2 is crucial. This paper considers effects on testing and positive tests for SARS-CoV-2 of re-opening Norwegian schools after a six-week closure to reduce contagion. We estimate the effect of school reopening for teachers, parents and students using an event study/difference-in-differences design with comparison groups with minimal exposure to in-person schooling. We find no evidence that incidence increased following re-opening for either students, parents, or teachers pooled across grade levels. We find some suggestive evidence that infection rates among upper secondary school teachers increased; however, quantitatively, the effects are small and transitory. At low levels of contagion, schools can safely be re-opened when other social distancing policies remain in place.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInternal funding by the Norwegian Institute of public healthAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by The Regional Committees for Medical and Health Research Ethics (REC) (#198964). Finn Wisloeff, Faculty of Medicine, University of Oslo Finn Skre Fjordholm, REK soeroest-D, REK, Oslo. Ethical approval was given All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSensitive data kept in repository